- Research works
- 22 ▲ 205% vs 2013–17
- Citations
- 52 2.4 per fractional work
- Top-10% rate
- 4.5% record average 16.5%
- Open access
- 48% world 28%
Not ranked overall: TransCure BioServices (France) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 11.8×. Every wedge is a field page.
Which keywords describe research at TransCure BioServices (France)?
By fractional works in all years, weighted toward what it does more of than the world: Immunotherapy, Glycosylation, Tumor Regression, Gene Therapy, Cancer Immunotherapy, Biopharmaceutical Production, Fc Receptors and Therapeutic Antibodies.
- Type 1 Diabetes
- Autoimmunity
- Inflammation
- Immune Response
- Viral Vectors
- NK Cell Recognition
- Epidemiology
- Arginine Deprivation
- Immunity
- Tumor Targeting
- Chimeric Antigen Receptor
- Recombinant Protein
- Therapeutic Antibodies
- Biopharmaceutical Production
- Gene Therapy
- Glycosylation
- Immunotherapy
- Tumor Regression
- Cancer Immunotherapy
- Fc Receptors
- Mammalian Cells
- CAR T Cells
- Lymphoma
- Genomic Integration
- Antiretroviral Therapy
- Bacterial Therapy
- AAV
- Natural Killer Cells
- HIV
- AIDS
- Vaccine
- Genetics
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 32 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 32 words, with their numbers
- Immunotherapy5▲ 36×4 topics
- Glycosylation4▲ 94×2 topics
- Tumor Regression4▲ 188×2 topics
- Gene Therapy3▲ 54×3 topics
- Cancer Immunotherapy3▲ 91×2 topics
- Biopharmaceutical Production3▲ 151×2 topics
- Fc Receptors2▲ 108×1 topic
- Therapeutic Antibodies2▲ 83×1 topic
- Mammalian Cells2▲ 253×1 topic
- Recombinant Protein2▲ 253×1 topic
- CAR T Cells2▲ 218×1 topic
- Chimeric Antigen Receptor2▲ 218×1 topic
- Lymphoma2▲ 65×2 topics
- Tumor Targeting2▲ 69×2 topics
- Genomic Integration2▲ 78×2 topics
- Immunity2▲ 22×3 topics
- Antiretroviral Therapy2▲ 30×3 topics
- Arginine Deprivation2▲ 157×1 topic
- Bacterial Therapy2▲ 157×1 topic
- Epidemiology2▲ 1.67×4 topics
- AAV1▲ 96×1 topic
- NK Cell Recognition1▲ 65×1 topic
- Natural Killer Cells1▲ 65×1 topic
- Viral Vectors1▲ 96×1 topic
- HIV1▲ 52×2 topics
- Immune Response1▲ 9.3×2 topics
- AIDS1▲ 102×1 topic
- Inflammation1▲ 2.4×4 topics
- Vaccine1▲ 13×1 topic
- Autoimmunity1▲ 23×2 topics
- Genetics1▲ 6.0×1 topic
- Type 1 Diabetes1▲ 50×1 topic
Which research topics does TransCure BioServices (France) publish most on?
By volume in 2022–2025: Viral Infectious Diseases and Gene Expression in Insects, Monoclonal and Polyclonal Antibodies Research, Virus-based gene therapy research and Diabetes and associated disorders.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 2 works
- 2 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
- 3 Virus-based gene therapy research Genetics 1 works
- 4 Diabetes and associated disorders Genetics 1 works
- 5 Advanced Biosensing Techniques and Applications Molecular Biology 1 works
- 6 CAR-T cell therapy research Oncology 1 works
- 7 bioluminescence and chemiluminescence research Molecular Biology 0 works
- 8 Immunotherapy and Immune Responses Immunology 0 works
- 9 Food Allergy and Anaphylaxis Research Immunology and Allergy 0 works
- 10 Animal Genetics and Reproduction Genetics 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has TransCure BioServices (France)'s research output changed?
Output in 2018–2022 was 205% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Archamps
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.